ALS Clinical Trials in Phoenix

Showing 41-58 of 58 trials

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

NCT02794857

This study evaluates NP001 in patients with amyotrophic lateral sclerosis (ALS) and evidence of systemic inflammation. Half of participants will receive NP001 and the other half will receive placebo.

Amyotrophic Lateral Sclerosis

Neuraltus Pharmaceuticals, Inc.138 participantsStarted Aug 2016

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +19 more locations

COMPLETED< 1 mile

Study of Electrical Impedance Myography (EIM) in ALS

NCT02011204

This trial is studying Electrical Impedance Myography (EIM) for measuring muscle health. The trial is studying people with Amyotrophic Lateral Sclerosis (ALS), other neuromuscular diseases, and healthy volunteers to see if the EIM device can measure disease in muscle tissue.

Amyotrophic Lateral SclerosisMotor Neuron DiseaseCharcot-Marie-Tooth Disease+1 more

Skulpt, Inc.106 participantsStarted Nov 2013

Phoenix, Arizona, United States • Miami, Florida, United States • Boston, Massachusetts, United States +3 more locations

PreviousPage 3 of 3

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

Study of Electrical Impedance Myography (EIM) in ALS

ALS Trials in Other Cities

Determining the Safety of L-serine in ALS

Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Minocycline to Treat Amyotrophic Lateral Sclerosis

Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy

Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

Creatine for the Treatment of Amyotrophic Lateral Sclerosis

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Talampanel for Amyotrophic Lateral Sclerosis (ALS)

Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

Other Conditions in Phoenix